Language Selection

Français

Detection of antibodies against Herpes B virus (Cercopithecine Herpesvirus 1) by ELISA

<<Return to Search Results

Requisition Forms

Reference Details

Description:

Detection of IgG antibodies in human sera following exposure to a monkey. Note that human IgG antibodies against HBV may be tested, but due to substantial cross-reactivity with HSV-1 and HSV-2, these may not be helpful and/or not tested.

Test Category:
Serology
Pathogen:
Herpes B virus (Cercopithecine Herpesvirus 1)
Illnesses and Diseases:
  • Encephalitis
Specimen:

Serum or plasma - minimum sample 0.5 mL.

Notice: As of May 1st, 2024 the Special Pathogens program will no longer accept non-human primate samples for HBV detection.  

Collection Method:

Collect in serum (red top) or serum separator tubes (SST), centrifugation of serum tubes is not needed and should be avoided. 

Specimen Processing, Storage and Shipping:

Store samples in refrigerator or frozen until being shipped for testing.  Serum can be shipped refrigerated or frozen. Ship frozen specimens on dry ice and refrigerated specimens on wet ice.

Transportation of Dangerous Goods:

Shipping of samples suspected of containing Risk Group 4 pathogens shall be done by a TDG certified individual in accordance with TDG regulations. If applicable, activate Emergency Response Assistance Plan (ERAP) 24 hours prior to shipping. To activate an ERAP, please click on the link below to access the transport flowchart for Risk Group 4 pathogens or call 204-999-7996 (available 24/7) for assistance.

Transport Flowchart for Risk Group 4 Pathogen(s)
Patient Criteria:

Symptomatic or recent contact to macaque monkeys. Paired acute and convalescent sera may be requested as it may assist on determining whether there has been an acute exposure to alphaherpesvirus. 

Accompanying Documentation:

Completed Special Pathogens requisition including sender name, address and telephone number. Patient information including name or identifier, date of birth, and all relevant patient history including clinical diagnosis, underlying diseases, exposure risk and travel history. Indicate type of specimen collected and all specimen information. Select all required tests. If possible, attach lab results that have already been done at local or provincial laboratories.

Comments:

All patient history must be included; sample without adequate patient history to justify testing are subject to rejection. Contact Special Pathogens prior to submission of sample to ensure appropriate shipping documentation is generated.

Non-routine test for investigational purposes.

Methods and Interpretation of Results:

For diagnosis of HBV infection to be confirmed, one or more of the following diagnostic markers must be positive: (i) presence of HBV virus by PCR, and (ii) isolation of HBV virus.

Turnaround Time:

14 calendar days

Contact:
Phone #: (204) 789-6019 or (204) 789-7032*
Fax: (204) 789-2140
References:

N/A

Guidelines:
Related Information: